Target intelligence / Profile preview

NIMA-related kinase 1 (protein kinase) (NEK1)

Target
NEK1
Molecular classification
Enzyme (serine/threonine protein kinase; EC 2.7.11.1), Protein kinase superfamily member (NEK family), Cell-cycle–related kinase family (NIMA-related kinases)
01

Overview

NIMA-related kinase 1 is a serine/threonine protein kinase of the NEK family that participates in centrosome dynamics, mitotic spindle assembly, primary cilium function, and is essential for early DNA damage response signaling, including priming of ATR and phosphorylation of Rad54. The human NEK1 kinase domain structure has been solved in apo and ATP-mimetic inhibitor-bound forms, supporting efforts to design selective inhibitors and suggesting possible use as chemo- or radiosensitizers. NEK1 is highly expressed in germ cells, has functional similarity to fungal NIMA in chromatin condensation, and its deficiency leads to defective checkpoint activation, chromosome breaks, aneuploidy, and tumor predisposition in mice. Mutations in NEK1 are associated with ciliopathies (including polycystic kidney disease), short-rib thoracic dysplasia, Mohr syndrome, and have been implicated in amyotrophic lateral sclerosis and cancers.

Other names
NEK1Kidney, anemia and testis (kat) mutant locus (mouse; historical/alias context)NIMA (never in mitosis gene A)-related kinase 1
02

Mechanism of action

ATP-competitive kinase inhibition of NEK1 (based on kinase domain structures with ATP-mimetic inhibitors; anticipated mechanism for experimental/tool inhibitors). Chemo- or radio-sensitization via NEK1 inhibition to impair DNA damage repair signaling (proposed based on structural/functional data).

03

Biological functions

DNA damage response signaling (early responder to ionizing radiation, primes ATR and phosphorylates Rad54)Cell-cycle regulation, including centrosome disjunction and mitotic spindle assembly (family-level functions with NEK1 involvement)Primary cilium function/ciliogenesis-related processesMeiosis/germ cell biology (high expression in germ cells; functional similarity to NIMA; affects chromatin condensation when mislocalized)Maintenance of genomic stability; checkpoint activation (CHK1/CHK2) and S/G2-M arrest after damageTumor suppressor-like roles in genome stability (heterozygous Nek1 mutant mice show higher lymphoma incidence)
04

Disease associations

Ciliopathies including polycystic kidney disease (mutations in Nek1 cause PKD-like phenotypes in mice; defects linked to human PKD)Short-rib thoracic dysplasia and Mohr syndrome (mutations reported)Amyotrophic lateral sclerosis (NEK1 implicated/mutated in ALS)Cancer (mutations reported; roles in DNA damage response, potential tumor suppression; increased lymphomas in Nek1+/− mice)
05

Safety considerations

On-target toxicity risk in proliferative tissues and germ cells due to roles in DNA damage response, genomic stability, meiosis, and ciliary function (potential for infertility, genomic instability, ciliopathy-like effects)Potential hematologic or neoplastic risks if NEK1 function is chronically suppressed, given tumor suppressor-like roles in mice
06

Interacting drugs

No approved, highly selective clinical NEK1 inhibitors are established; structural studies report ATP-mimetic inhibitor binding to the NEK1 kinase domain (tool-like ligands used crystallographically)

1 more in the full profile.

07

Biomarkers

NEK1 loss-of-function or pathogenic variants as genetic biomarkers in ALS and ciliopathies (e.g., short-rib thoracic dysplasia) and PKD contextsNEK1 expression/activity or mutation status as a potential biomarker of DNA damage response competence and sensitivity to genotoxic therapy (inferred from essential role in ATR/CHK signaling)

Beyond the preview

Go deeper on NIMA-related kinase 1 (protein kinase) (NEK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIMA-related kinase 1 (protein kinase) (NEK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call